Medicinova

MNOVNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$65.956 M

$1.34 -1.47%

Close of 7 Aug 2026

Revenue

$409.7K

#3564 by revenue

Earnings

$12.0M

#2017 by earnings

Shares outstanding

49,221,246

Latest filing cover page

P/E ratio

5.5

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#335Nomad Power SolutionsNMAD$68.3M
#336CleneCLNN$67.5M
#337MedicinovaMNOV$66.0M
#338Annovis BioANVS$65.1M
#339Pliant TherapeuticsPLRX$65.0M

Where these numbers come from

Share counts and financials for Medicinova are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.